Samples for study ST001924
Species: Homo sapiens (Factor headings shown in green)mb_sample_id | Subject name | Sample name | Factor | Sample_Data:RAW_FILE_NAME | Sample description | NMR experiment | Acquisition setting ID number | Gender | Race | BMI | Smoker | Age | Metastatic | SubTypes | Nuclear Grade | Grade | Stage | Tumor Width | Note |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SA178019 | - | 1000 | - | 1000 | - | HSQC | Acquistion-2 | - | - | - | - | - | - | - | - | - | - | - | Derives its content from all samples in the study. |
SA178018 | - | 2000 | - | 2000 | - | HSQC-TOCSY | Acquistion-3 | - | - | - | - | - | - | - | - | - | - | - | Derives its content from all samples in the study. |
SA178038 | - | 100 | Early | 100 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 25.7 | Never | 61.9 | No | Pure Clear Cell | 2 | Low | 1 | 1 | Not applicable |
SA178033 | - | 102 | Early | 102 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 21.1 | Never | 47.2 | No | Pure Clear Cell | 2 | Low | 1 | 3 | Not applicable |
SA178020 | - | 115 | Early | 115 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 33.3 | Former | 62.5 | No | Pure Clear Cell | 3 | High | 1 | 4.2 | Not applicable |
SA178045 | - | 116 | Early | 116 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 32.5 | Current | 35.1 | No | Pure Clear Cell | 3 | High | 1 | 3.5 | Not applicable |
SA178056 | - | 119 | Early | 119 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 25 | Former | 69.2 | No | Pure Clear Cell | 2 | Low | 1 | 2 | Not applicable |
SA178021 | - | 136 | Early | 136 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Female | White | 26.3 | Current | 60.2 | No | Pure Clear Cell | 3 | High | 1 | 5 | Not applicable |
SA178046 | - | 160 | Early | 160 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Male | White | 27.2 | Former | 77.4 | No | Papillary | 3 | High | 1 | 4.3 | Not applicable |
SA178027 | - | 162 | Early | 162 | Clear Cell Papillary | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 37.1 | Never | 53 | No | Clear Cell Papillary | 2 | Low | 1 | 2.2 | Not applicable |
SA178040 | - | 166 | Early | 166 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | White | 36.3 | Never | 64.2 | No | Pure Clear Cell | 4 | High | 1 | 5.2 | Not applicable |
SA178051 | - | 171 | Early | 171 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 27.2 | Never | 50.8 | No | Pure Clear Cell | 2 | Low | 2 | 10.1 | Not applicable |
SA178023 | - | 196 | Early | 196 | Chromophobe carcinoma | 1D 1H NOESY | Acquistion-1 | Female | White | 27.4 | Former | 55.4 | No | Chromophobe | 4 | High | 1 | 4.1 | Not applicable |
SA178044 | - | 210 | Early | 210 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 30 | Never | 39.7 | No | Papillary | 3 | High | 2 | 10.6 | Not applicable |
SA178024 | - | 217 | Early | 217 | Chromophobe carcinoma | 1D 1H NOESY | Acquistion-1 | Male | White | 30 | Never | 80.1 | No | Chromophobe | 4 | High | 1 | 5.2 | Not applicable |
SA178042 | - | 221 | Early | 221 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | American-Indian/Alaskan-Native | 25 | Never | 46.2 | No | Pure Clear Cell | 2 | Low | 1 | 3.9 | Not applicable |
SA178025 | - | 223 | Early | 223 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 31 | Never | 55.6 | No | Papillary | 3 | High | 1 | 3.5 | Not applicable |
SA178052 | - | 227 | Early | 227 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 23.6 | Current | 60.3 | No | Papillary | 2 | Low | 2 | 10 | Not applicable |
SA178030 | - | 23 | Early | 23 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 24.4 | Never | 38.1 | No | Pure Clear Cell | 2 | Low | 1 | 2.9 | Not applicable |
SA178031 | - | 232 | Early | 232 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 35.2 | Never | 60.5 | No | Pure Clear Cell | 2 | Low | 1 | 1.5 | Not applicable |
SA178055 | - | 244 | Early | 244 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 26.7 | Former | 55.8 | No | Pure Clear Cell | 3 | High | 1 | 2.7 | Not applicable |
SA178053 | - | 263 | Early | 263 | Chromophobe carcinoma | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 24.9 | Never | 56 | No | Chromophobe | 3 | High | 2 | 11.5 | Not applicable |
SA178035 | - | 271 | Early | 271 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 24.4 | Never | 67.8 | No | Pure Clear Cell | 3 | High | 1 | 1.6 | Not applicable |
SA178047 | - | 275 | Early | 275 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 30.7 | Never | 59.8 | No | Clear Cell Papillary | 2 | Low | 1 | 3.9 | Not applicable |
SA178032 | - | 277 | Early | 277 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 24.7 | Former | 83.7 | No | Papillary | 3 | High | 2 | 8 | Not applicable |
SA178057 | - | 282 | Early | 282 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 38.4 | Former | 55.1 | No | Pure Clear Cell | 3 | High | 1 | 3.3 | Not applicable |
SA178037 | - | 284 | Early | 284 | Clear Cell Papillary | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 21.7 | Never | 66.3 | No | Chromophobe | 3 | High | 1 | 3.5 | Not applicable |
SA178059 | - | 286 | Early | 286 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 41 | Former | 72.9 | No | Pure Clear Cell | 3 | High | 2 | 9.5 | Not applicable |
SA178036 | - | 30 | Early | 30 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 42.1 | Former | 68.2 | No | Pure Clear Cell | 2 | Low | 1 | 5 | Not applicable |
SA178022 | - | 317 | Early | 317 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 28.5 | Never | 32.6 | No | Pure Clear Cell | 2 | Low | 1 | 1.7 | Not applicable |
SA178034 | - | 326 | Early | 326 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 31 | Never | 76.4 | No | Pure Clear Cell | 3 | High | 1 | 2.6 | Not applicable |
SA178029 | - | 332 | Early | 332 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 29 | Former | 76.7 | No | Pure Clear Cell | 2 | Low | 1 | 1.4 | Not applicable |
SA178054 | - | 341 | Early | 341 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | - | - | 21.5 | Never | 80 | No | Papillary | 3 | High | 1 | 2.5 | Not applicable |
SA178049 | - | 38 | Early | 38 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Female | White | 34.6 | Never | 53.7 | No | Unclassified | 3 | High | 2 | 8.2 | Not applicable |
SA178058 | - | 4 | Early | 4 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 36.4 | Never | 52.8 | No | Pure Clear Cell | 2 | Low | 1 | 3.9 | Not applicable |
SA178039 | - | 64 | Early | 64 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 31.3 | Former | 76.2 | No | Papillary | 2 | Low | 1 | 3.8 | Not applicable |
SA178050 | - | 70 | Early | 70 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Male | White | 31 | Never | 38.2 | No | Pure Clear Cell | 2 | Low | 2 | 8.2 | Not applicable |
SA178041 | - | 75 | Early | 75 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 21.7 | Never | 72.4 | No | Clear Cell Papillary | 2 | Low | 1 | 1 | Not applicable |
SA178028 | - | 77 | Early | 77 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 32.7 | Former | 82.9 | No | Pure Clear Cell | 3 | High | 1 | 4.1 | Not applicable |
SA178060 | - | 84 | Early | 84 | Papillary RCC | 1D 1H NOESY | Acquistion-1 | Female | White | 31.6 | Current | 61.6 | No | Papillary | 2 | Low | 1 | 5.5 | Not applicable |
SA178048 | - | 89 | Early | 89 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 31.4 | Former | 62.3 | No | Papillary | 2 | Low | 1 | 2.2 | Not applicable |
SA178043 | - | 91 | Early | 91 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 30.9 | Never | 61.2 | No | Clear Cell Papillary | 2 | Low | 1 | 2.2 | Not applicable |
SA178026 | - | 94 | Early | 94 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Male | White | 30.6 | Never | 60.4 | No | Pure Clear Cell | 2 | Low | 1 | 2.1 | Not applicable |
SA178084 | - | 105 | Late | 105 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Asian | 15.7 | Never | 73 | No | Pure Clear Cell | 3 | High | 3 | 11.4 | Not applicable |
SA178076 | - | 110 | Late | 110 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Female | White | 23.9 | Never | 74.5 | Yes | Pure Clear Cell | 4 | High | 4 | 9.4 | Not applicable |
SA178062 | - | 117 | Late | 117 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | White | 18.5 | Never | 55.6 | Yes | Pure Clear Cell | 4 | High | 4 | 5.5 | Not applicable |
SA178085 | - | 125 | Late | 125 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | White | 27.7 | Former | 75.5 | No | Papillary | 4 | High | 3 | 5.5 | Not applicable |
SA178072 | - | 142 | Late | 142 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Male | White | 18.2 | Current | 67.7 | No | Pure Clear Cell | 3 | High | 3 | 10 | Not applicable |
SA178083 | - | 150 | Late | 150 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 31 | Former | 72.4 | No | Pure Clear Cell | 2 | Low | 3 | 10.8 | Not applicable |
SA178069 | - | 156 | Late | 156 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Male | White | 23 | Never | 30.2 | Yes | Unclassified | 3 | High | 4 | 10.4 | Not applicable |
SA178066 | - | 167 | Late | 167 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 36.8 | Former | 58 | Yes | Pure Clear Cell | 3 | High | 4 | 10.2 | Not applicable |
SA178067 | - | 168 | Late | 168 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 26.2 | Never | 52.3 | Yes | Pure Clear Cell | 3 | High | 4 | 11 | Not applicable |
SA178087 | - | 175 | Late | 175 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 29.4 | Never | 66.6 | No | Pure Clear Cell | 4 | High | 3 | 12.8 | Not applicable |
SA178064 | - | 186 | Late | 186 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 17.4 | Current | 56.6 | No | Pure Clear Cell | 4 | High | 3 | 6 | Not applicable |
SA178089 | - | 201 | Late | 201 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 34 | Former | 77.1 | No | Pure Clear Cell | 4 | High | 3 | 5.5 | Not applicable |
SA178061 | - | 233 | Late | 233 | Chromophobe carcinoma | 1D 1H NOESY | Acquistion-1 | Female | White | 29.7 | Never | 36.7 | Yes | Pure Clear Cell | 2 | Low | 4 | 2 | Not applicable |
SA178065 | - | 236 | Late | 236 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 25 | Former | 81.1 | No | Pure Clear Cell | 3 | High | 3 | 4.7 | Not applicable |
SA178071 | - | 245 | Late | 245 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 31.7 | Former | 68.8 | Yes | Pure Clear Cell | 3 | High | 4 | 8.5 | Not applicable |
SA178077 | - | 253 | Late | 253 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | White | 35.4 | Never | 60.9 | No | Pure Clear Cell | 4 | High | 3 | 10.3 | Not applicable |
SA178074 | - | 258 | Late | 258 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 23.5 | Never | 67 | Yes | Pure Clear Cell | 4 | High | 3 | 6.7 | Not applicable |
SA178081 | - | 26 | Late | 26 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Unk/Missing | 30.2 | Never | 31 | No | Pure Clear Cell | 3 | High | 3 | 15 | Not applicable |
SA178075 | - | 27 | Late | 27 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 31 | Former | 76.6 | Yes | Pure Clear Cell | 4 | High | 4 | 9.5 | Not applicable |
SA178070 | - | 272 | Late | 272 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Female | White | 23.9 | Never | 59.4 | Yes | Pure Clear Cell | 4 | High | 4 | 11.2 | Not applicable |
SA178080 | - | 29 | Late | 29 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 26.4 | Never | 69.5 | No | Pure Clear Cell | 3 | High | 3 | 5.3 | Not applicable |
SA178086 | - | 303 | Late | 303 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Female | White | 38.5 | Never | 58.3 | Yes | Pure Clear Cell | 4 | High | 4 | 5.5 | Not applicable |
SA178082 | - | 308 | Late | 308 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 29.5 | Never | 42.5 | Yes | Pure Clear Cell | 4 | High | 4 | 27 | Not applicable |
SA178063 | - | 32 | Late | 32 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 38 | Never | 62.1 | No | Pure Clear Cell | 4 | High | 3 | 18 | Not applicable |
SA178073 | - | 331 | Late | 331 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | Mixed | 24.9 | Never | 43.3 | No | Pure Clear Cell | 4 | High | 3 | 11 | Not applicable |
SA178088 | - | 42 | Late | 42 | Cancer (Other) | 1D 1H NOESY | Acquistion-1 | Male | White | 33.6 | Former | 65.6 | Yes | Unclassified | 4 | High | 4 | 3.5 | Not applicable |
SA178068 | - | 71 | Late | 71 | Clear Cell Papillary | 1D 1H NOESY | Acquistion-1 | Female | Black/AA | 30.5 | Never | 64.3 | Yes | Pure Clear Cell | 2 | Low | 4 | 7.7 | Not applicable |
SA178079 | - | 73 | Late | 73 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 37.3 | Never | 58.8 | No | Pure Clear Cell | 3 | High | 3 | 9.3 | Not applicable |
SA178078 | - | 82 | Late | 82 | Sarcomatoid | 1D 1H NOESY | Acquistion-1 | Male | White | 21.8 | Never | 45.2 | Yes | Pure Clear Cell | 4 | High | 4 | 12.4 | Not applicable |
SA178097 | - | 131 | Unknown | 131 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 29.4 | Current | 67 | No | Pure Clear Cell | 2 | Low | Unknown | 6 | Not applicable |
SA178090 | - | 153 | Unknown | 153 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 24.7 | Never | 84.8 | No | Pure Clear Cell | 3 | High | Unknown | 4.7 | Not applicable |
SA178094 | - | 161 | Unknown | 161 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 32.2 | Never | 44.7 | No | Pure Clear Cell | 2 | Low | Unknown | 4 | Not applicable |
SA178092 | - | 218 | Unknown | 218 | Chromophobe carcinoma | 1D 1H NOESY | Acquistion-1 | Male | White | 34.2 | Never | 64 | No | Chromophobe | Unknown | Unknown | Unknown | 5.5 | Not applicable |
SA178093 | - | 230 | Unknown | 230 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 32.2 | Former | 55.7 | Yes | Pure Clear Cell | 2 | Low | Unknown | 2.4 | Not applicable |
SA178096 | - | 262 | Unknown | 262 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 31 | Never | 71.7 | No | Clear Cell Papillary | Unknown | Unknown | Unknown | Unknown | Not applicable |
SA178095 | - | 293 | Unknown | 293 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 27.8 | Never | 59 | No | Pure Clear Cell | 2 | Low | Unknown | 2 | Not applicable |
SA178091 | - | 316 | Unknown | 316 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 30.6 | Never | 64.9 | No | Pure Clear Cell | 2 | Low | Unknown | 3 | Not applicable |
SA178099 | - | 79 | Unknown | 79 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Female | White | 28.1 | Former | 56 | Yes | Pure Clear Cell | Unknown | Unknown | Unknown | Unknown | Not applicable |
SA178098 | - | 8 | Unknown | 8 | Clear Cell Papillary | 1D 1H NOESY | Acquistion-1 | Female | Unk/Missing | 45 | Former | 64.5 | No | Clear Cell Papillary | 2 | Low | Unknown | 3.2 | Not applicable |
SA178100 | - | 85 | Unknown | 85 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | White | 31 | Never | 74.9 | No | Pure Clear Cell | 3 | High | - | 8.4 | Not applicable |
SA178101 | - | 9 | Unknown | 9 | Pure Clear Cell Cancer | 1D 1H NOESY | Acquistion-1 | Male | Black/AA | 29 | Never | 45.8 | No | Unclassified | Unknown | Unknown | Unknown | 2 | Not applicable |